drugset / Trial / NCT03404648
Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to find out if a PET/MR scan in combination with standard MRI and CT scans can improve the early detection and treatment of patients with prostate cancer.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2020-01-23
- Completion
- 2020-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C-11 choline PET tracer | Diagnostic / imaging agent | 444 mbq | Intravenous |
| Subject | C-11 choline PET tracer | Diagnostic / imaging agent | 518 mbq | Intravenous |
| Background | Gadobutrol | Diagnostic / imaging agent | 0.1 unknown | Intravenous |